Trade Bristol Myers ^BMY

Ritholtz Wealth Management Boosts Stock Position in Bristol Myers Squibb Company $BMY

OP Asset Management Ltd Takes Position in Bristol Myers Squibb Company $BMY

The case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapy

Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

Bristol Myers Follows Novartis, Sues Arkansas Over Pharmacy Law

Faithward Advisors LLC Grows Stock Holdings in Bristol Myers Squibb Company $BMY

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study

Bristol Myers Squibb (NYSE:BMY) Shares Unloaded Rep. Mike Kelly - Stock Observer

Bristol-Myers Squibb Company (BMY) and SystImmune Announce Results from Analyses of Iza-bren Studies

Bristol Myers Squibb (BMY) Stock Could Be 13% Undervalued As Pipeline Plans Take Shape

Brookstone Capital Management Acquires 35,588 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Holdings Lifted by Corient Private Wealth LLC

Innovent-Pfizer deal makes joint development, commercialization pillar in biotech global push - Chinadaily.com.cn

Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial

Keytruda Market Trends, Analysis and Forecast - Express Press Release Distribution

KRAS Inhibitors Market is Poised for Robust Growth by 2036 Driven by Expanding KRAS-Targeted Therapies and Rising Adoption Across Multiple Oncology Indications | DelveInsight

SG Americas Securities LLC Purchases 5,399,407 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020

Kera Capital Partners Inc. Buys Shares of 9,554 Bristol Myers Squibb Company $BMY - Zolmax

Bristol Myers Squibb Company $BMY Shares Acquired by AEGON ASSET MANAGEMENT UK Plc

Uhlmann Price Securities LLC Has $927,000 Stake in Bristol Myers Squibb Company $BMY - Daily Political

Wick Capital Partners LLC Invests $608,000 in Bristol Myers Squibb Company $BMY - Daily Political

Revolutionizing Cancer Diagnosis: How Next-Generation Sequencing is Changing Lives, ETHealthworld

Union Savings Bank Purchases New Position in Bristol Myers Squibb Company $BMY - Zolmax

Union Savings Bank Takes Position in Bristol Myers Squibb Company $BMY - Daily Political

2,059,000 Shares in Bristol Myers Squibb Company $BMY Purchased by Employees Provident Fund Board - Daily Political

Kovitz Investment Group Partners LLC Trims Holdings in Bristol Myers Squibb Company $BMY

Hamilton Wealth LLC Lowers Position in Bristol Myers Squibb Company $BMY - Stock Observer

Pacer Advisors Inc. Sells 925,559 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer

Asset One Wealth Management LLC Purchases New Position in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Bought by Independent Franchise Partners LLP

Investment Management Corp of Ontario Has $16.63 Million Stake in Bristol Myers Squibb Company $BMY

Catalio Capital Management LP Buys Shares of 647,899 Bristol Myers Squibb Company $BMY

Asset One Wealth Management LLC Buys New Stake in Bristol Myers Squibb Company $BMY

Banco Bilbao Vizcaya Argentaria S.A. Sells 14,852 Shares of Bristol Myers Squibb Company $BMY

Armistice Capital LLC Decreases Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol-Myers Squibb (BMY) Maintains Quarterly Dividend at $0.63

Kardigan raises $400M in upsized US IPO, pricing at top of range

Bristol Myers Squibb (BMY) Reports Strong Myeloma Trial Results And Early CAR T Progress

How John Tsai plans to keep Daiichi Sankyo ahead in the ADC game

BREYANZI® CAR T Cell Therapy Monitoring and Activity Updates Approved in Canada

Interest Rates Are Going Higher: 4 High-Yield Passive Income Stocks Can Weather Any Storm

Russell Investments Group Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager for Saudi Arabia & Gulf Countries

Berkshire Asset Management LLC PA Buys 38,329 Shares of Bristol Myers Squibb Company $BMY

Harvest Investment Advisors LLC Acquires New Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Rep. Mike Kelly Sells Bristol Myers Squibb Company (NYSE:BMY) Shares

Edgewise data power rival to BMS and Cytokinetics toward phase 3

Bristol Myers Squibb (BMY) Stock Could Be 10.7% Undervalued After Kidney Cancer Trial Expansion

Sofinnova Investments Inc. Makes New Investment in Bristol Myers Squibb Company $BMY

Capital Financial Group Inc. Co. ADV Invests $660,000 in Bristol Myers Squibb Company $BMY - Markets Daily

Aster Capital Management DIFC Ltd Acquires New Shares in Bristol Myers Squibb Company $BMY

Vanguard Personalized Indexing Management LLC Acquires 16,823 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Aster Capital Management DIFC Ltd Buys New Stake in Bristol Myers Squibb Company $BMY - Daily Political

Why counting women is not enough: from inclusion to equity in oncology trials

Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases

BMY Faces Headline Risk Amid Medicare Drug Price Negotiation Proposals

A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers Squibb

Bristol Myers Squibb Company $BMY Shares Sold by Arax Advisory Partners

Epoch Investment Partners Inc. Purchases 131,472 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Arrowstreet Capital Limited Partnership Buys 2,356,583 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Vontobel Holding Ltd. Sells 248,546 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Shares Sold by Cullen Capital Management LLC

Bristol Myers Squibb Company $BMY Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Stock Observer

Bristol Myers Squibb Company $BMY Shares Acquired by Van ECK Associates Corp - Daily Political

Banco Santander S.A. Has $44.45 Million Stock Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Victory Capital Management Inc. - Daily Political

Regeneron Broadens Pipeline With Ebola Antibody Trials And Bispecific Cancer Bets

CMS Proposes Permanent Framework for Medicare Drug Price Negotiations

Takeda's zasocitinib bests Sotyktu in phase III psoriasis trial | BioWorld

Bristol Myers Squibb Company $BMY Stake Lifted by Xponance LLC

Swiss National Bank Has $300.86 Million Stake in Bristol Myers Squibb Company $BMY

IFM Investors Pty Ltd Raises Stake in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Position Raised by Sector Gamma AS - Stock Observer

Bristol Myers Squibb Company $BMY Shares Sold by Colrain Capital LLC

Takeda's AI-Enhanced Psoriasis Pill Outshines Bristol Myers' Sotyktu in Key Trial, ETPharma

Takeda (TAK) Shows Strong Efficacy of Zasocitinib in Psoriasis Trial

Is Arcus Biosciences (RCUS) Using the ROSETTA Trial Tie-Up to Quietly Reframe Its RCC Strategy?

Takeda's TYK2 inhibitor beats BMS' Sotyktu in psoriasis showdown

Deutsche Bank AG Buys 226,088 Shares of Bristol Myers Squibb Company $BMY

M Holdings Securities Inc. Buys Shares of 44,462 Bristol Myers Squibb Company $BMY - Stock Observer

Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor

Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

Camzyos Priority Review And New Oncology Data Could Be A Game Changer For Bristol-Myers Squibb (BMY)

WINTON GROUP Ltd Takes Position in Bristol Myers Squibb Company $BMY - Zolmax

Motley Fool Asset Management LLC Purchases 50,403 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Stock Holdings Raised by Cerity Partners LLC